Live Breaking News & Updates on Coronary artery disease branch

Stay informed with the latest breaking news from Coronary artery disease branch on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Coronary artery disease branch and stay connected to the pulse of your community

Cold weather may raise the risk of this heart problem

Cold weather may raise the risk of this heart problem
washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.

United-states , American , Yves-rosenberg , Jonathan-piccini , Mohitk-turagam , Paul-wang , Journal-of-the-american-heart-association , Artery-disease-branch , Arrhythmia-service , Centers-for-disease , Drug-administration , American-heart-association

Researchers find that targeting immune cells may help treat atrial fibrillation: New study finds that macrophages and macrophage-produced proteins contribute to heartbeat irregularities

Researchers find that targeting immune cells may help treat atrial fibrillation: New study finds that macrophages and macrophage-produced proteins contribute to heartbeat irregularities
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

Massachusetts , United-states , United-kingdom , American , British , Gregoryr-wojtkiewicz , Richardn-pierson , Maarten-hulsmans , Maximilianj-schloss , Constanze-bening , I-hsiu-lee , Aneesh-bapat

Macrophages may play a major role in the development of atrial fibrillation

Current treatments for atrial fibrillation (AFib), a common heart condition characterized by fast and irregular beats that can lead to stroke and heart failure, have multiple side effects and are ineffective for preventing AFib recurrence.

United-kingdom , Massachusetts , United-states , British , American , Serguei-melnitchouk , George-tellides , Claudio-vinegoni , Samuel-sossalla , Richardn-pierson , Deutsche-forschungsgemeinschaft , David-rohde

Researchers find that targeting immune cells may help treat atrial fibrillation

Researchers find that targeting immune cells may help treat atrial fibrillation
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Massachusetts , United-states , Matthias-nahrendorf , Division-of-cardiovascular-sciences , Artery-disease-branch , Men-health , Blood-institute , National-heart , Research-institute , Massachusetts-general-hospital , Systems-biology , Richard-moerschner-endowed

Research Links Red Meat Intake, Gut Microbiome, and Cardiovascular Disease in Older Adults

Microbiome-related metabolites, blood sugar, and inflammation appear more important than blood cholesterol in mediating heart disease due to meat intake.

Ahmed-hasan , Meng-wang , Amanda-fretts , Dariush-mozaffarian , Stanleyl-hazen , University-of-washington-department-epidemiology , Friedman-school , Atherothrombosis-coronary-artery-disease-branch , Network-openin , National-heart , Blood-institute , Coronary-artery-disease-branch

How does red meat raise heart disease risk?

"The interactions between red meat, our gut microbiome, and the bioactive metabolites they generate seem to be an important pathway for risk..."

United-states , Americans , Ahmed-hasan , Meng-wang , Dariush-mozaffarian , Stanleyl-hazen , Friedman-school , National-institutes-of-health , Tufts-university , Cardiovascular-health-study , Atherothrombosis-coronary-artery-disease-branch , Friedman-school-of-nutrition-science

Gut Microbiome an Important Meat Intake-Related Mediator of Heart Disease Risk in Older Adults

Microbiome-related metabolites like TMAO, as well as blood sugar and general inflammation, appear more important than blood cholesterol or blood pressure in mediating heart disease risk associated with meat intake.

United-states , Americans , Ahmed-hasan , Meng-wang , Amanda-fretts , Dariush-mozaffarian , Stanleyl-hazen , Friedman-school , National-institutes-of-health , Cleveland-clinic-lerner-research-institute , Tufts-university , University-of-washington-department-epidemiology

Study quantifies link between red meat intake, gut microbiome, and cardiovascular disease in older adults

Does eating more meat-;especially red meat and processed meat-;raise the risk of cardiovascular disease, and if so, why? Despite intense study, the impact of animal source foods on atherosclerotic cardiovascular disease (ASCVD) is vigorously debated, and the mechanisms underlying potential effects of animal proteins remain unclear.

United-states , Americans , Ahmed-hasan , Meng-wang , Zeneng-wang , Dariush-mozaffarian , Stanleyl-hazen , Emily-henderson , Rozenn-lemaitre , Amanda-fretts , Friedman-school , National-institutes-of-health

Results of the COLCORONA study published in The Lancet Respiratory Medicine - News Makers

Results of the COLCORONA study published in The Lancet Respiratory Medicine - News Makers
newsmakers.pk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsmakers.pk Daily Mail and Mail on Sunday newspapers.

South-africa , Montreal , Quebec , Canada , United-states , America , Canadian , Sophie-desmarais , Jean-claude-tardif , Yves-rosenberg , Montreal-heart-institute , Mastercard

COLCORONA study shows that colchicine can reduce complications in certain COVID-19 patients

COLCORONA study shows that colchicine can reduce complications in certain COVID-19 patients
The Montreal Heart Institute (MHI) announces that the COLCORONA study results are published today in The Lancet Respiratory Medicine.
The article, which is entitled Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomized, double-blinded, adaptive, placebo-controlled, multicentre trial, concludes that, given the lack of oral therapies available to prevent COVID-19 complications among non-hospitalized patients and the observed benefit of colchicine in patients with a PCR-confirmed diagnosis of COVID-19, this anti-inflammatory drug could be considered as a treatment for those at risk of complications.
Given the current pandemic, while awaiting collective immunity through vaccination around the world, the need for treatments to prevent COVID-19 complications among patients who contract the disease remains. Our study showed that colchicine could be used to reduce the risk of complications for some patients with COVID-19."

South-africa , Montreal , Quebec , Canada , United-states , America , Jean-claude-tardif , Yves-rosenberg , Emily-henderson , Montreal-heart-institute , Artery-disease-branch , United-states-national-institutes-of-health